Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TBPH Theravance Biopharma

10.010
-0.130-1.28%
Trading Session 10/03 14:54 ET
High
10.209
Open
10.130
Turnover
4.92M
Low
9.920
Pre Close
10.140
Volume
489.94K
Market Cap
668.49M
P/E(TTM)
Loss
52wk High
13.170
Shares
66.78M
P/E(Static)
Loss
52wk Low
7.470
Float Cap
294.96M
Bid/Ask %
-20.00%
Historical High
124.866
Shs Float
29.47M
Volume Ratio
0.61
Historical Low
6.100
Dividend TTM
--
Div Yield TTM
--
P/B
-1.91
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.66%
Amplitude
2.85%
Avg Price
10.034
Lot Size
1
Float Cap
294.96M
Bid/Ask %
-20.00%
Historical High
124.866
Shs Float
29.47M
Volume Ratio
0.61
Historical Low
6.100
Dividend TTM
--
P/B
-1.91
Dividend LFY
--
Turnover Ratio
1.66%
Amplitude
2.85%
Avg Price
10.034
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
CEO: Mr. Rick E. Winningham
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...